Fairjourney Biologics acquires Charles River Laboratories South San Francisco facility

FHS
March 5, 2025
3:55 am

FairJourney Biologics S.A., leaders in the discovery and optimization of antibodies, today announced that it had completed the acquisition of the South San Francisco site from Charles River Laboratories International, Inc.

How DOGE is hitting CMS, and another go with transparency

This is the online version of STAT’s email newsletter Health Care Inc, delivered to your inbox every Monday. Sign up here. Hello and welcome. I’ll tell

March 3, 2025

Cancer-causing gene also plays a crucial role in aging, study finds

A gene called Myc (pronounced “mick”) that is among the most important drivers of cancer in both mice and humans also plays a newly discovered

July 24, 2023

Summit Therapeutics touts a rare triumph over Keytruda in lung cancer from a China-only Phase 3 study

Hours before America’s biggest cancer conference starts in Chicago, a small biotech may have stolen the show, touting late-stage results in a Thursday afternoon press

May 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.